Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.

Original languageEnglish (US)
Pages (from-to)185-197
Number of pages13
JournalThe Lancet Neurology
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Neuromyelitis Optica
Multiple Sclerosis
Spinal Cord
Spinal Cord Diseases
Biomarkers
Outcome Assessment (Health Care)
Clinical Trials
Sensitivity and Specificity

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (2019). Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. The Lancet Neurology, 18(2), 185-197. https://doi.org/10.1016/S1474-4422(18)30460-5

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. / International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

In: The Lancet Neurology, Vol. 18, No. 2, 01.02.2019, p. 185-197.

Research output: Contribution to journalReview article

International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders 2019, 'Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders', The Lancet Neurology, vol. 18, no. 2, pp. 185-197. https://doi.org/10.1016/S1474-4422(18)30460-5
International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. The Lancet Neurology. 2019 Feb 1;18(2):185-197. https://doi.org/10.1016/S1474-4422(18)30460-5
International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. / Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. In: The Lancet Neurology. 2019 ; Vol. 18, No. 2. pp. 185-197.
@article{5ddf1a2db24f4d2b993b9603078bba3a,
title = "Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders",
abstract = "Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.",
author = "{International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders} and Olga Ciccarelli and Cohen, {Jeffrey A.} and Reingold, {Stephen C.} and Weinshenker, {Brian G} and Amato, {Maria Pia} and Brenda Banwell and Frederik Barkhof and Bruce Bebo and Burkhard Becher and Fran{\cc}ois Bethoux and Alexander Brandt and Wallace Brownlee and Peter Calabresi and Jeremy Chatway and Claudia Chien and Tanuja Chitnis and Jeffrey Cohen and Giancarlo Comi and Jorge Correale and {De S{\`e}ze}, Jerome and {De Stefano}, Nicola and Franz Fazekas and Eoin Flanagan and Mark Freedman and Kazuo Fujihara and Steven Galetta and Myla Goldman and Benjamin Greenberg and Hartung, {Hans Peter} and Bernhard Hemmer and Anke Henning and Izlem Izbudak and Ludwig Kappos and Hans Lassmann and Cornelia Laule and Michael Levy and Fred Lublin and Lucchinetti, {Claudia F} and Carsten Lukas and Marrie, {Ruth Ann} and Aaron Miller and David Miller and Xavier Montalban and Ellen Mowry and Sebastien Ourselin and Friedemann Paul and Daniel Pelletier and Ranjeva, {Jean Philippe} and Daniel Reich and Stephen Reingold",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/S1474-4422(18)30460-5",
language = "English (US)",
volume = "18",
pages = "185--197",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

AU - International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

AU - Ciccarelli, Olga

AU - Cohen, Jeffrey A.

AU - Reingold, Stephen C.

AU - Weinshenker, Brian G

AU - Amato, Maria Pia

AU - Banwell, Brenda

AU - Barkhof, Frederik

AU - Bebo, Bruce

AU - Becher, Burkhard

AU - Bethoux, François

AU - Brandt, Alexander

AU - Brownlee, Wallace

AU - Calabresi, Peter

AU - Chatway, Jeremy

AU - Chien, Claudia

AU - Chitnis, Tanuja

AU - Cohen, Jeffrey

AU - Comi, Giancarlo

AU - Correale, Jorge

AU - De Sèze, Jerome

AU - De Stefano, Nicola

AU - Fazekas, Franz

AU - Flanagan, Eoin

AU - Freedman, Mark

AU - Fujihara, Kazuo

AU - Galetta, Steven

AU - Goldman, Myla

AU - Greenberg, Benjamin

AU - Hartung, Hans Peter

AU - Hemmer, Bernhard

AU - Henning, Anke

AU - Izbudak, Izlem

AU - Kappos, Ludwig

AU - Lassmann, Hans

AU - Laule, Cornelia

AU - Levy, Michael

AU - Lublin, Fred

AU - Lucchinetti, Claudia F

AU - Lukas, Carsten

AU - Marrie, Ruth Ann

AU - Miller, Aaron

AU - Miller, David

AU - Montalban, Xavier

AU - Mowry, Ellen

AU - Ourselin, Sebastien

AU - Paul, Friedemann

AU - Pelletier, Daniel

AU - Ranjeva, Jean Philippe

AU - Reich, Daniel

AU - Reingold, Stephen

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.

AB - Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85060049167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060049167&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(18)30460-5

DO - 10.1016/S1474-4422(18)30460-5

M3 - Review article

VL - 18

SP - 185

EP - 197

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 2

ER -